Revizinone
Revizinone is a novel selective phosphodiesterase (PDE) inhibitor with IC50 values on this enzyme to 0.036 microM. target: phosphodiesterase (PDE) [3]; IC 50: 0.036 microM; [3] In vivo: The administration of Revizinone improved the haemodynamic profile with an increase in cardiac output, a decrease in systemic vascular resistance and a stable heart rate and mean arterial blood pressure. [1] With regard to reconstitution of contractility and cardiac function Revizinone (E-isomer) was 10 fold more potent than R 79595 and nearly 100 fold more potent than R 80123 (Z-isomer) . [2] Revizinone significantly increased global LV function and systolic wall thickening in ischemic areas at doses greater than or equal to 0.16 mg/kg i.v. [4]
Product Specifications
CAS Number
133718-29-3
Product Name Alternative
R80122
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Revizinone.html
Concentration
10mM
Purity
99.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C1CCCCC1)C)CO/N=C(C2=CC=CC=C2)/C3=CC4=C(N=C(NC(C5)=O)N5C4)C=C3
Molecular Formula
C26H29N5O3
Molecular Weight
459.55
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cadmium Selenide Zinc Sulfide Quantum Dots 525nm - Alkyl
![3-[4-Aminomethyl) benzyloxy]thalidomide BP-1-108 Amide](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
3-[4-Aminomethyl) benzyloxy]thalidomide BP-1-108 Amide
3-[4-Aminomethyl) benzyloxy]thalidomide BP-1-108 Amide
Phospho-Bcl-2 (Thr129) Polyclonal Antibody, AbBy Fluor™ 405 Conjugated
Phospho-CDK7 (Thr170) Rabbit Polyclonal Antibody (Cy3)